<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03782545</url>
  </required_header>
  <id_info>
    <org_study_id>C-18-TS-18</org_study_id>
    <nct_id>NCT03782545</nct_id>
  </id_info>
  <brief_title>Multi-Center Pilot Study of Cutera truSculpt Device</brief_title>
  <official_title>Multi-Center Pilot Study of Cutera truSculpt Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cutera Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cutera Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Exploratory study to evaluate the safety, efficacy and ergonomics of Cutera truSculpt device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will evaluate the safety, efficacy and ergonomics of Cutera truSculpt device.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">December 1, 2018</start_date>
  <completion_date type="Anticipated">May 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>A type of intervention model describing a clinical trial in which all participants receive the same intervention/treatment.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>This is an open label study.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence and severity of adverse device effects.</measure>
    <time_frame>up to 12 week follow up</time_frame>
    <description>Incidence and severity of adverse device effects.</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Treatment for Cellulite on the Stomach and Flanks</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cutera truSculpt Device</intervention_name>
    <description>The Cutera truSculpt Device uses radio frequency (RF) energy to provide topical heating for the purpose of elevating tissue temperature for the treatment of selected medical conditions, such as temporary reduction in the appearance of cellulite.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Subject must be able to read, understand and sign the Informed Consent Form.

             2. Female or Male, 18 to 65 years of age (inclusive). 3. Subject has visible fat
             bulges in the area to be treated. 4. Non-smoking for at least 6 months and willing to
             refrain from smoking for the duration of the study.

             5. Subject must agree to not undergo any other procedure(s) in the treatment region
             during the study period.

             6. Subject must adhere to the follow-up schedule and study instructions. 7. Subject
             must adhere to the same diet and/or exercise routine throughout the study, and agree
             to maintain the same weight throughout the study.

             8. Willing to have photographs taken of the treatment area and agree to use of
             photographs for presentation, (educational and/or marketing), publications, and any
             additional marketing purposes.

             9. For female subjects: not pregnant or lactating and is either post-menopausal,
             surgically sterilized, or using a medically acceptable form of birth control prior to
             enrollment and during the entire course of the study.

        Exclusion Criteria:

          1. Participation in a clinical trial of another device or drug within 1 month of study
             participation, or during the study period.

          2. Any type of prior cosmetic treatment to the target area within 6 months of study
             participation.

          3. Any prior invasive cosmetic surgery to the target area, such as liposuction.

          4. Has a pacemaker, internal defibrillator, implantable cardioverter-defibrillator, nerve
             stimulator implant, cochlear implant or any other electronically, magnetically or
             mechanically activated implant.

          5. Has metal implant(s) within the body, such as artificial heart valves.

          6. Significant uncontrolled concurrent illness that in the opinion of the Investigator
             would make the subject unsuitable for inclusion.

          7. History of any disease or condition that could impair wound healing.

          8. History of keloid formation, hypertrophic scarring or abnormal/delayed wound healing.

          9. Skin abnormality in the treatment area that in the opinion of the Investigator would
             make the subject unsuitable for inclusion.

         10. Currently undergoing systemic chemotherapy or radiation treatment for cancer, or
             history of treatment in the target area within 3 months of study participation.

         11. Allergy or sensitivity to Tegaderm.

         12. As per the Investigator's discretion, any physical or mental condition which might
             make it unsafe for the subject to participate in this study or a condition that would
             compromise the subject's ability to comply with the study requirements.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Laser and Skin Surgery Center of Northern California</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95816</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Advanced Dermatology</name>
      <address>
        <city>Glencoe</city>
        <state>Illinois</state>
        <zip>60022</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Union Square Dermatology</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2018</verification_date>
  <study_first_submitted>December 17, 2018</study_first_submitted>
  <study_first_submitted_qc>December 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2018</study_first_posted>
  <last_update_submitted>December 19, 2018</last_update_submitted>
  <last_update_submitted_qc>December 19, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cellulite</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Researchers involved in the study will have access to the final study data.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

